Selank: How a Tuftsin-Based Peptide Reduces Anxiety Without Drowsiness and Dependence

Imagine a medication that relieves anxiety as effectively as diazepam, but doesn't cause drowsiness, doesn't dull thinking, and doesn't form dependence. Sounds like a dream? For over 60 participants in a clinical study, this became reality. Selank — a synthetic peptide developed based on the natural immune peptide tuftsin — demonstrates a unique action profile: it calms the nervous system through the same receptors as benzodiazepines, but bypasses their dangerous side effects.

And here's what's interesting: this peptide could become a real discovery for those struggling with stress eating during weight loss programs with GLP-1 agonists. But more on that later.

What is Selank and where did it come from?

Selank is a synthetic heptapeptide of seven amino acids in the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro [15]. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in collaboration with the V.V. Zakusov Research Institute of Pharmacology back in the 1980s-1990s [18].

The molecular basis is tuftsin, a natural tetrapeptide that is a fragment of human immunoglobulin G heavy chain. Tuftsin itself has immunomodulatory properties, but its molecule is too unstable for therapeutic use [18]. Therefore, scientists added three additional amino acids (Pro-Gly-Pro) to stabilize the structure and extend the duration of action [3].

The result is a drug that received official approval in Russia as an anxiolytic (anti-anxiety agent) [5]. This is one of the few synthetic neuropeptides to achieve such regulatory status in its country of origin [15]. However, the FDA (USA) and EMA (Europe) have not yet approved Selank for clinical use — it remains a subject of research [13].

Selank's molecular mass is 753.9 Da, making it small enough to penetrate the blood-brain barrier [5]. This ability allows the peptide to act directly on neurons.

How Selank works: GABA, BDNF, serotonin

Selank is not a classical drug with a single point of action. Its mechanism encompasses several neurochemical systems simultaneously, making it unique among anxiolytics [2].

GABA system modulation

GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter of the central nervous system. It reduces neuronal excitability and creates a feeling of calm. Benzodiazepines (such as diazepam or medazepam) act precisely through GABA-A receptors, binding directly to them [3].

Selank acts differently. Grigoriev and colleagues in 2006 published direct evidence that Selank interacts with the benzodiazepine binding site of the GABA-A receptor complex in rodent preparations, acting as a positive allosteric modulator of GABA responses [2]. Simply put, it doesn't block or directly activate the receptor — it enhances the natural action of GABA.

This difference explains why Selank doesn't cause sedation, memory impairment, or physical dependence — typical side effects of benzodiazepines [3].

BDNF elevation

BDNF (Brain-Derived Neurotrophic Factor) is a protein that supports neuron survival, promotes formation of new synaptic connections, and plays a key role in learning and memory [6]. Low BDNF levels are linked to anxiety disorders, depression, and cognitive decline [6].

Studies show that Selank increases BDNF mRNA expression in rodent hippocampus [2]. BDNF activates TrkB receptors, triggering signaling cascades involved in synaptic plasticity and neuron survival [2]. This explains not only the anxiolytic but also the nootropic (cognitive enhancement) potential of the peptide.

Serotonin and dopamine

Selank affects the metabolism and turnover of serotonin and dopamine — key neurotransmitters involved in mood regulation and stress responses [4]. Research demonstrates:

• Upregulation of serotonin metabolism in the brainstem [7]
• Modulation of dopamine and noradrenaline concentrations [7]
• Stabilization of neurotransmitter balance under stress conditions [7]

Neurochemical analyses show that Selank normalizes stress-induced disturbances in monoamine systems, preventing depletion of serotonin, dopamine, and noradrenaline in stress-sensitive brain regions [11].

Enkephalin system

Selank inhibits enzymes that break down enkephalins — endogenous opioid peptides with natural anti-stress action [3]. This prolongs the duration of natural signals for stress reduction [3].

AC-Selank-NH2 vs regular Selank: which form is better?

Two main forms of Selank exist in the peptide market: classical Selank and the modified version AC-Selank-NH2 (acetylated, amidated). How do they differ?

Structural modifications

AC-Selank-NH2 has two key chemical modifications:

1. Acetyl group (AC-) at the N-terminus of the molecule
2. Amide group (-NH2) at the C-terminus

These modifications don't change the basic mechanism of action but significantly affect pharmacokinetics — how the body processes the peptide [27].

Stability and bioavailability

Acetylation protects the N-terminus of the peptide from degradation by aminopeptidases — enzymes that break down peptides in the blood. C-terminus amidation protects from carboxypeptidases. Together, these modifications extend the plasma half-life of the molecule [27].

Expected result: AC-Selank-NH2 demonstrates higher bioavailability due to improved stability in both blood plasma and tissues [27].

Blood-brain barrier penetration

Both forms penetrate the blood-brain barrier (BBB). Interestingly, with intranasal administration, peptides can partially bypass the BBB using direct pathways through olfactory nerves [35]. This is particularly relevant for nasal forms of Selank.

Studies show that intranasal administration typically provides higher CNS bioavailability compared to injection, as it bypasses first-pass liver metabolism [3]. Intranasal Selank bioavailability reaches 92.8% [3] — an exceptionally high rate for a peptide drug.

In the DOZA catalog, AC-Selank is available — a modified injectable form with improved bioavailability.

Clinical study: Selank vs medazepam

The most cited clinical study of Selank was conducted by a group led by A.A. Zozulya. The results are impressive in their clarity.

Study design

• Type: randomized controlled trial (RCT)
• Participants: 62 patients with generalized anxiety disorder (GAD) and neurasthenia
• Groups: 30 patients received intranasal Selank, 32 received oral medazepam (benzodiazepine)
• Duration: 14 days [3]

Key results

Both groups demonstrated similar anxiolytic efficacy on Hamilton, Zung, and CGI scales: -85% vs -83% [3]. But the similarities end there.

Selank showed additional benefits that medazepam lacked:

• Anti-asthenic effect — reduction of fatigue and weakness
• Psychostimulant effect — improved activity and motivation
• Absence of sedation — patients didn't experience drowsiness
• No dependence — no withdrawal symptoms [3]

The study also recorded increased enkephalin activity in blood serum, which correlated with anxiolytic effect [3].

Other clinical data

A separate placebo-controlled study (n=60) showed:

• 62% reduction on HAM-A (Hamilton Anxiety Rating Scale)
• Statistically significant improvement compared to placebo (p <0.01)
• Onset of anxiolytic action within 3-5 days
• No sedation, cognitive impairment, or withdrawal symptoms [20]

Cognitive functions: memory, focus, neuroplasticity

Selank demonstrates nootropic potential that goes beyond simple anxiety relief. Its impact on cognitive functions is related to several mechanisms.

BDNF and neuroplasticity

Increased BDNF expression promotes:

• Synaptogenesis — formation of new connections between neurons
• Memory consolidation — transition of information from short-term to long-term
• Cognitive flexibility — ability to adapt to new tasks [6]

Preclinical models show nootropic effects on memory and learning [5]. Selank also demonstrates neuroprotection against ethanol-induced memory impairments through BDNF regulation in the hippocampus [5].

Attention and concentration

Clients often report:

• Improved ability to maintain attention on complex tasks
• Enhanced information retention — better memorization
• Greater analytical clarity [14]

These effects are explained by modulation of serotonin (mood stability) and dopamine (motivation, focus) [4].

Comparison with Semax

Semax — another nootropic peptide of Russian development — is often compared to Selank. But their focus is different:

• Selank primarily affects GABA and serotonin — stress, relaxation, emotional balance
• Semax increases dopamine and BDNF — motivation, cognitive endurance, memory formation [8]

For comprehensive cognitive support, it's worth considering Nootropics Booster, which combines the benefits of various nootropic mechanisms.

Selank for stress eating and GLP-1 therapy

Here's the practical aspect that's particularly relevant for DOZA clients.

The anxiety and overeating cycle

Anxiety and weight management exist in a bidirectional relationship. Stress triggers cortisol release, which:

• Promotes abdominal fat accumulation
• Increases appetite for high-calorie foods [25]

Weight gain itself becomes a source of stress and anxiety. This cycle makes weight loss particularly difficult for people with elevated baseline anxiety [25].

How Selank can help

Selank interrupts this cycle on several levels:

1. Direct anxiety reduction — decreases stress-induced eating behaviors
2. Lower cortisol — improves metabolic function
3. Better emotional regulation — reduces likelihood of dietary protocol breakdown [25]

Selank affects serotonin metabolism, promoting a more balanced emotional state. Serotonin is often called the "feel-good neurotransmitter" [10]. Better mood means less emotional eating.

Important: Selank is not a weight loss drug. It is not FDA-approved for this purpose and is not a direct appetite control agent [26]. But for people whose weight problems are rooted in chronic stress and emotional overeating, it can be a useful addition to a comprehensive weight loss program.

If you're already taking Mounjaro or considering GLP-1 therapy, discuss with a DOZA specialist the possibility of including Selank in your protocol — especially if anxiety is one of your factors.

Dosing: nasal vs injectable administration

Nasal administration

Nasal sprays are the most common method of Selank use in Russia. Advantages:

• Bioavailability up to 92.8% [3]
• Rapid absorption — minutes
• Direct CNS access through olfactory pathways
• Convenience of self-administration

Typical dosing: 200-300 μg/kg daily, divided into 2-3 administrations [16]. Clinical studies used 300 μg/kg intranasally, 5 μL in each nostril [16].

Injectable administration

Subcutaneous injections provide:

• More precise dosing
• More stable pharmacokinetics
• Higher predictability of effect

AC-Selank-NH2 in injectable form has improved plasma stability due to molecular modifications [27].

Selank vs Noopept vs Phenibut: what to choose?

Three popular nootropics with different mechanisms and action profiles. Let's compare them for informed choice.

Selank

Best suited for: anxiety + need for clear thinking. Ideal when you need to calm down but stay productive.

Advantages: no sedation or dependence, cognitive support, immunomodulation.

Limitations: less pronounced nootropic effect compared to Noopept; limited evidence base outside Russia [12].

Noopept

Noopept is a dipeptide analog of pyroglutamyl and primarily affects neurotrophic factors (BDNF, NGF) and AMPA receptors.

Best suited for: cognitive enhancement without pronounced anxiety.

Advantages: rapid onset, low doses (10-30 mg), broad nootropic activity profile.

Limitations: minimal anxiolytic effect.

Phenibut

Phenibut is a GABA derivative with direct GABA-B receptor agonism.

Best suited for: pronounced anxiety, social phobia, insomnia.

Advantages: powerful anxiolytic and sedative effect.

Limitations: dependence risk with long-term use, sedation may interfere with productivity, withdrawal syndrome with abrupt cessation [12].

DOZA recommendation

For clients seeking a balance between anxiety relief and cognitive support without the risk of dependency, AC-Selank is the optimal choice. For enhanced cognitive support, consider combining with Nootropics Booster.

Safety and potential interactions

Selank's safety profile appears favorable based on available data.

Recorded side effects

According to Russian clinical data, rarely reported [5]:

• Mild sedation (rare)
• Dizziness (rare)
• Headache (rare, usually mild)

Key difference from benzodiazepines: no dependence recorded — this is consistently emphasized as the drug's main advantage [5].

Potential interactions

Potential interaction risk with GABAergic drugs (including benzodiazepines) is documented in preclinical studies [13]. This is logical given the mechanism of action — both drug classes affect the GABA system.

Research showed that combining Selank with diazepam enhanced anxiolytic effect under unpredictable chronic stress conditions in rats [16]. This may have both positive (synergy) and negative (excessive effect) consequences.

Contraindications

Formally established contraindications for Selank include:

• Allergy to components
• Pregnancy and lactation (insufficient data)
• Concurrent use with benzodiazepines (requires monitoring)

Practical aspects of use

Who is Selank suitable for?

Based on mechanism of action and available data, Selank may be useful for [4]:

• People with generalized anxiety who want to avoid sedation
• Those needing cognitive clarity during stress
• Clients on GLP-1 therapy with stress eating
• People seeking alternatives to benzodiazepines

Who should be cautious?

• Those already taking GABAergic drugs
• People with severe psychiatric disorders (specialist monitoring needed)
• Those expecting immediate and powerful effects (Selank acts more gently than benzodiazepines) [12]

How to order from DOZA?

AC-Selank is available in the DOZA catalog for 3,800 UAH. This is a modified injectable form with improved stability. Before ordering, we recommend taking a free consultation to select the optimal protocol considering your goals.

Where to buy

DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:

• Buy Selank in Ukraine — anxiolytic peptide against stress eating, non-addictive.

FAQ — Frequently Asked Questions about Selank

What is Selank in simple terms?

Selank is a synthetic peptide of seven amino acids, created based on the natural immune peptide tuftsin. It reduces anxiety and improves cognitive functions without drowsiness or dependence typical of traditional sedatives.

Does Selank cause dependence?

According to clinical studies, Selank does not cause physical dependence or withdrawal symptoms. This fundamentally distinguishes it from benzodiazepines and is one of the drug's main advantages.

How quickly does Selank start working?

The anxiolytic effect manifests within 3-5 days after starting the course. Some users feel relief earlier, but stable effects develop gradually.

What's the difference between regular Selank and AC-Selank?

AC-Selank-NH2 has additional chemical modifications that protect the molecule from enzyme degradation. This extends duration of action and increases bioavailability compared to regular Selank.

Can Selank be combined with weight loss medications?

Selank can be a useful addition to GLP-1 therapy for clients with stress eating. It reduces anxiety and improves emotional regulation, making it easier to stick to a nutrition plan. However, specific combinations should be approved by a specialist.

What's better: Selank or Noopept?

It depends on your goals. Selank is better for anxiety relief while maintaining clear thinking. Noopept is for cognitive enhancement without pronounced anxiety. Some protocols involve their combination.

Is Selank approved by the FDA or in Ukraine?

Selank is approved as an anxiolytic only in Russia. The FDA, EMA, and Ukrainian regulators have not approved the drug for clinical use. In Ukraine, it's available as a research peptide.

Can Selank be taken nasally instead of by injection?

Yes, nasal forms of Selank have high bioavailability up to 92.8 percent. However, the injectable form AC-Selank provides more precise dosing and more stable pharmacokinetics.

Selank efficacy data looks promising, especially for people seeking an anxiolytic without typical benzodiazepine side effects. The mechanism of action is well-studied at the preclinical level. However, Western independent studies remain limited.

If anxiety interferes with your life or complicates your weight loss program — this is worth discussing with a specialist. DOZA offers an individual approach to selecting peptide protocols considering your specific goals and conditions. The first step is a free consultation.